Business Daily from THE HINDU group of publications
Tuesday, April 8, 2008 ePaper | Mobile/PDA Version


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Subscription

Group Sites

News Update as at 18.00 hrs (IST)


Corporate
JB Chemicals board approves buyback of equity shares

MUMBAI: JB Chemicals & Pharmaceuticals Ltd has informed the BSE that the board of directors of the Company at its meeting held on April 8 has approved the buyback of equity shares at a maximum price not exceeding Rs 70 per share and up to an aggregate am ount of Rs 29.52 crore, being within 7.05% of the total paid-up capital and free reserves as per the audited Balance Sheet as at March 31, 2007.

The company proposes to buy back shares listed on the BSE and the NSE through open market purchases from time to time.

The maximum price is at a premium of 41.27% over the closing price of Rs 49.55 of the company's share on the NSE as on April 7. The average closing price of the Company's share on the BSE for the last six months is Rs 64.

Prev: C & C Constructions wins EPC contract worth Rs 574 cr
Next: Hero Honda to pump in additional Rs 150 crore in Haridwar


Business Line | NUS Index |


Related Topics
Alliances & Joint Ventures
Announcements
Auditing
Awards & Honours
Bonus Announcements
Company Law
Corporate Bonds
Corporate Disputes
Corporate Governance
Courts/Legal Issues
Diversification
Environment
Human Resources
Interview
IPOs
IPR
Management
Mergers & Acquisitions
New Projects
Open Offers
Outlook
Outsourcing
Overseas Borrowings
Overseas Investments
People
Performance
Preferential Allotments
Private Placement
Regulatory Bodies & Rulings
Research & Development
Restructuring
Rights Issue
Sick Units
Society & Development
Standards & Benchmarks
Taxation
Trade & Labour Unions



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line